BPC-157 can only be legally sold for authorised trials, conducted by qualified researchers
Blum et al (2003) presented a new family of bioisostere inhibitors, based on the structure of AG 538, a tyrphostin inhibiting the IGF-1R TK at the substrate level and not at the ATP binding site (Blum et al, 2000)
Dihexa is a synthetic peptide originally developed by researchers at Washington State University as part of a program to create therapies for Alzheimers disease and cognitive decline
However, established damage not reversed, benefits limited to slowing progression and preventing further deterioration
Kikuchi Y, Hayatsu M, Hosokawa T, Nagayama A, Tago K, Fukatsu T
And every new trial has only reinforced my knowing it is THE gold standard for GLP-1 peptides